Filters close
Released: 22-Feb-2017 12:05 PM EST
Georgia State Offers New Interdisciplinary Graduate Degree Programs in Biomedical Sciences
Georgia State University

The Institute for Biomedical Sciences (IBMS) at Georgia State University is offering two new graduate degree programs designed to prepare students for careers in the biomedical sciences that will enhance human health and bring scientific discoveries to market.

Released: 20-Feb-2017 11:05 AM EST
Biomarker Predicts Poor Prognosis in African-Americans with Triple-Negative Breast Cancer, Study Finds
Georgia State University

Having high levels of a certain biomarker is linked to poor prognosis in African-American patients with triple-negative breast cancer, while the same biomarker doesn’t influence disease outcomes in white patients, according to a new study.

Released: 13-Feb-2017 10:05 AM EST
Career Educator Noma LeMoine to Speak at 28th Annual Benjamin E. Mays Lecture
Georgia State University

Noma LeMoine, chief educational officer of LeMoine and Associates Educational Consulting, will deliver the 28th annual Benjamin E. Mays Lecture on Feb. 21 at 6:30 p.m. in the Georgia State University Student Center East Ballroom (55 Gilmer St. SE, Atlanta).

Released: 8-Feb-2017 12:05 PM EST
Georgia State Neuroscientist Receives $1.8 Million NIH Grant to Investigate Pain Treatment for Elderly
Georgia State University

Dr. Anne Murphy, a neuroscientist of Georgia State University, has received a five-year, $1.8 million grant from the National Institutes of Health (NIH), to investigate pain management therapies for people aged 65 or older.

Released: 19-Jan-2017 2:05 PM EST
Breast Cancer Prognosis of African-American Patients May Improve with Administration of Chemotherapy Before Surgery, Study Finds
Georgia State University

Administering chemotherapy to African-American breast cancer patients prior to surgery could improve their prognosis and survival rates from the disease, according to a new study.

Released: 17-Jan-2017 10:05 AM EST
GeoVax to Collaborate with Georgia State on Development of Hepatitis B Therapeutic Vaccine
Georgia State University

The Georgia State University Research Foundation has entered into a research collaboration agreement with GeoVax Labs, Inc., a Georgia-based biotechnology company developing human vaccines, to advance development of a therapeutic vaccine for treatment of chronic Hepatitis B infections.

Released: 3-Jan-2017 8:05 AM EST
Enzyme Could Protect Against Type of Colorectal Cancer By Suppressing Tumors, Study Finds
Georgia State University

An enzyme that plays an active role in inflammation could be a natural way to suppress tumors and ulcers in the colon that are found in colitis associated cancer (CAC), a type of colorectal cancer that is driven by chronic inflammation, according to a new study.



close
0.13426